SEC 13F Intelligence

Consonance Capital Management LP / CYTK

Consonance Capital Management LP’s Cytokinetics Inc Position

Does Consonance Capital Management LP own Cytokinetics Inc (CYTK)? Not currently — the last reported position was 3.35M shares worth $79M in Q2 2020; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$79M
Q2 2020
Shares
3.35M
% of Portfolio
+4.73%
Quarters Held
2
position exited

Position History CYTK

Reported value by quarter
Q1 ’20: $40MQ1 ’20Q2 ’20: $79MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20203.35M$79M+4.73%
Q1 20203.43M$40M+3.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of CYTK.